Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (46)
Grazia Castellano, Federica Giugliano, Giuseppe Curigliano & Antonio Marra. (2023) Clinical utility of genomic signatures for the management of early and metastatic triple-negative breast cancer. Current Opinion in Oncology 35:6, pages 479-490.
Crossref
Crossref
Lilian Marie Boll, Júlia Perera-Bel, Alejo Rodriguez-Vida, Oriol Arpí, Ana Rovira, Núria Juanpere, Sergio Vázquez Montes de Oca, Silvia Hernández-Llodrà, Josep Lloreta, M. Mar Albà & Joaquim Bellmunt. (2023) The impact of mutational clonality in predicting the response to immune checkpoint inhibitors in advanced urothelial cancer. Scientific Reports 13:1.
Crossref
Crossref
Hirotaka Miyashita, Razelle Kurzrock, Nicholas J. Bevins, Kartheeswaran Thangathurai, Suzanna Lee, Sarabjot Pabla, Mary Nesline, Sean T. Glenn, Jeffrey M. Conroy, Paul DePietro, Eitan Rubin, Jason K. Sicklick & Shumei Kato. (2023) T-cell priming transcriptomic markers: implications of immunome heterogeneity for precision immunotherapy. npj Genomic Medicine 8:1.
Crossref
Crossref
Romualdo Barroso-Sousa, Jana Priscila Pacífico, Sarah Sammons & Sara M. Tolaney. (2023) Tumor Mutational Burden in Breast Cancer: Current Evidence, Challenges, and Opportunities. Cancers 15:15, pages 3997.
Crossref
Crossref
Yekbun Adiguzel, Naim Mahroum, Sylviane Muller, Miri Blank, Gilad Halpert & Yehuda Shoenfeld. (2023) Shared Pathogenicity Features and Sequences between EBV, SARS-CoV-2, and HLA Class I Molecule-binding Motifs with a Potential Role in Autoimmunity. Clinical Reviews in Allergy & Immunology 65:2, pages 206-230.
Crossref
Crossref
Xiang-Yu Meng. (2023) “Paradoxical neoantigenic mutations”: not simply a driver vs passenger dualism. British Journal of Cancer 129:1, pages 1-2.
Crossref
Crossref
Pia Pužar Dominkuš & Petra Hudler. (2023) Mutational Signatures in Gastric Cancer and Their Clinical Implications. Cancers 15:15, pages 3788.
Crossref
Crossref
Pieter A. Roelofs, John W.M. Martens, Reuben S. Harris & Paul N. Span. (2023) Clinical Implications of APOBEC3-Mediated Mutagenesis in Breast Cancer. Clinical Cancer Research 29:9, pages 1658-1669.
Crossref
Crossref
Francisco Martínez-Jiménez, Peter Priestley, Charles Shale, Jonathan Baber, Erik Rozemuller & Edwin Cuppen. (2023) Genetic immune escape landscape in primary and metastatic cancer. Nature Genetics 55:5, pages 820-831.
Crossref
Crossref
Yanlin Tang, Changzheng Zhang, Chujin Ye, Kaiwen Tian, Jiayi Zeng, Shouyu Cheng, Weinan Zeng, Bowen Yang, Yanjun Liu & Yuming Yu. (2023) Construction and validation of programmed cell death-based molecular clusters for prognostic and therapeutic significance of clear cell renal cell carcinoma. Heliyon 9:5, pages e15693.
Crossref
Crossref
Pieter A. Roelofs, Mieke A. M. Timmermans, Bojana Stefanovska, Myrthe A. den Boestert, Amber W. M. van den Borne, Hayri E. Balcioglu, Anita M. Trapman, Reuben S. Harris, John W. M. Martens & Paul N. Span. (2023) Aberrant APOBEC3B Expression in Breast Cancer Is Linked to Proliferation and Cell Cycle Phase. Cells 12:8, pages 1185.
Crossref
Crossref
Adam Wahida, Lars Buschhorn, Stefan Fröhling, Philipp J. Jost, Andreas Schneeweiss, Peter Lichter & Razelle Kurzrock. (2022) The coming decade in precision oncology: six riddles. Nature Reviews Cancer 23:1, pages 43-54.
Crossref
Crossref
Jiayue Qiu, Xiangmei Li, Yalan He, Qian Wang, Ji Li, Jiashuo Wu, Ying Jiang & Junwei Han. (2022) Identification of comutation in signaling pathways to predict the clinical outcomes of immunotherapy. Journal of Translational Medicine 20:1.
Crossref
Crossref
Isaias Hernández-Verdin, Kadir C. Akdemir, Daniele Ramazzotti, Giulio Caravagna, Karim Labreche, Karima Mokhtari, Khê Hoang-Xuan, Matthieu Peyre, Franck Bielle, Mehdi Touat, Ahmed Idbaih, Alex Duval, Marc Sanson & Agustí Alentorn. (2022) Pan-cancer landscape of AID-related mutations, composite mutations, and their potential role in the ICI response. npj Precision Oncology 6:1.
Crossref
Crossref
Nicholas J. Bevins, Ryosuke Okamura, Meagan Montesion, Jacob J. Adashek, Aaron M. Goodman & Razelle Kurzrock. (2022) Tumor Infiltrating Lymphocyte Expression of PD-1 Predicts Response to Anti-PD-1/PD-L1 Immunotherapy. Journal of Immunotherapy and Precision Oncology 5:4, pages 90-97.
Crossref
Crossref
Chunnan Liu, Zhaopei Liu, Kaifeng Jin, Han Zeng, Fei Shao, Yuan Chang, Yiwei Wang, Le Xu, Zewei Wang, Yu Zhu & Weijuan Zhang. (2022) Integrative tumour mutation burden with CD39 and PD-L1 for the prediction of response to PD-L1 blockade and adjuvant chemotherapy in muscle-invasive bladder cancer patients. British Journal of Cancer 127:9, pages 1718-1725.
Crossref
Crossref
Melissa C. Leeolou, Nareh Marukian Burgren, Carolyn S. Lee, Arash Momeni, Harlan Pinto, Peter Johannet, Cara Liebert, Kristin M. Nord & Anne Lynn S. Chang. (2022) Recurrent bilateral cutaneous squamous cell carcinoma arising within hypertrophic lichen planus with metastasis while on cemiplimab. JAAD Case Reports 29, pages 55-58.
Crossref
Crossref
Hyun Ae Jung, Jinyeong Lim, Yoon-La Choi, Se-Hoon Lee, Je-Gun Joung, Yeong Jeong Jeon, Jae Won Choi, Sumin Shin, Jong Ho Cho, Hong Kwan Kim, Yong Soo Choi, Jae Ill Zo, Young Mog Shim, Sehhoon Park, Jong-Mu Sun, Jin Seok Ahn, Myung-Ju Ahn, Joungho Han, Woong-Yang Park, Jhingook Kim & Keunchil Park. (2022) Clinical, Pathologic, and Molecular Prognostic Factors in Patients with Early-Stage EGFR-Mutant NSCLC. Clinical Cancer Research 28:19, pages 4312-4321.
Crossref
Crossref
Richard S P Huang, Lukas Harries, Brennan Decker, Matthew C Hiemenz, Karthikeyan Murugesan, James Creeden, Khaled Tolba, Laura P Stabile, Shakti H Ramkissoon, Timothy F Burns & Jeffrey S Ross. (2022) Clinicopathologic and Genomic Landscape of Non-Small Cell Lung Cancer Brain Metastases. The Oncologist 27:10, pages 839-848.
Crossref
Crossref
Cody J. Warren, Mario L. SantiagoDohun Pyeon. (2022) APOBEC3: Friend or Foe in Human Papillomavirus Infection and Oncogenesis?. Annual Review of Virology 9:1, pages 375-395.
Crossref
Crossref
Bernadett Szabados, Mariano Ponz-Sarvisé, Robson Machado, Diego Saldana, Edward E. Kadel, Romain Banchereau, Fanny Bouquet, Marius Garmhausen, Thomas Powles & Carsten Schröder. (2022) Clinico-Genomic Characterization of Patients with Metastatic Urothelial Carcinoma in Real-World Practice Identifies a Novel Bladder Immune Performance Index (BIPI). Clinical Cancer Research 28:18, pages 4083-4091.
Crossref
Crossref
Nithya Krishnamurthy, Shumei Kato, Scott Lippman & Razelle Kurzrock. (2022) Chromatin remodeling (SWI/SNF) complexes, cancer, and response to immunotherapy. Journal for ImmunoTherapy of Cancer 10:9, pages e004669.
Crossref
Crossref
Amélie Boichard & Razelle Kurzrock. (2022) Variable Mutation Expression in Human Cancers: A “Hide-and-Seek” Mechanism Linked to Differential MHC-I Presentation Dynamics. Molecular Cancer Therapeutics 21:7, pages 1219-1226.
Crossref
Crossref
Shiro Takamatsu, Junzo Hamanishi, J B Brown, Ken Yamaguchi, Koji Yamanoi, Kosuke Murakami, Osamu Gotoh, Seiichi Mori, Masaki Mandai & Noriomi Matsumura. (2022) Mutation burden-orthogonal tumor genomic subtypes delineate responses to immune checkpoint therapy. Journal for ImmunoTherapy of Cancer 10:7, pages e004831.
Crossref
Crossref
Yunzhen Qian, Yitao Gong, Xuan Zou, Yu Liu, Yusheng Chen, Ruijie Wang, Zhengjie Dai, Yesiboli Tasiheng, Xuan Lin, Xu Wang, Guopei Luo, Xianjun Yu, He Cheng & Chen Liu. (2022) Aberrant APOBEC3C expression induces characteristic genomic instability in pancreatic ductal adenocarcinoma. Oncogenesis 11:1.
Crossref
Crossref
Ahmed Halima, Winston Vuong & Timothy A. Chan. (2022) Next-generation sequencing: unraveling genetic mechanisms that shape cancer immunotherapy efficacy. Journal of Clinical Investigation 132:12.
Crossref
Crossref
O. N. Shilova, D. L. Tsyba & E. S. Shilov. (2022) Mutagenic Activity of AID/APOBEC Deaminases in Antiviral Defense and Carcinogenesis. Molecular Biology 56:1, pages 46-58.
Crossref
Crossref
Joris L. Vos, Joris B. W. Elbers, Oscar Krijgsman, Joleen J. H. Traets, Xiaohang Qiao, Anne M. van der Leun, Yoni Lubeck, Iris M. Seignette, Laura A. Smit, Stefan M. Willems, Michiel W. M. van den Brekel, Richard Dirven, M. Baris Karakullukcu, Luc Karssemakers, W. Martin C. Klop, Peter J. F. M. Lohuis, Willem H. Schreuder, Ludi E. Smeele, Lilly-Ann van der Velden, I. Bing Tan, Suzanne Onderwater, Bas Jasperse, Wouter V. Vogel, Abrahim Al-Mamgani, Astrid Keijser, Vincent van der Noort, Annegien Broeks, Erik Hooijberg, Daniel S. Peeper, Ton N. Schumacher, Christian U. Blank, Jan Paul de Boer, John B. A. G. Haanen & Charlotte L. Zuur. (2021) Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma. Nature Communications 12:1.
Crossref
Crossref
Timothy V. Pham, Aaron M. Goodman, Smruthy Sivakumar, Garrett Frampton & Razelle Kurzrock. (2021) Intra-patient stability of tumor mutational burden from tissue biopsies at different time points in advanced cancers. Genome Medicine 13:1.
Crossref
Crossref
Thomas Powles, Srikala S. Sridhar, Yohann Loriot, Joaquim Bellmunt, Xinmeng Jasmine Mu, Keith A. Ching, Jie Pu, Cora N. Sternberg, Daniel P. Petrylak, Rosa Tambaro, Louis M. Dourthe, Carlos Alvarez-Fernandez, Maureen Aarts, Alessandra di Pietro, Petros Grivas & Craig B. Davis. (2021) Avelumab maintenance in advanced urothelial carcinoma: biomarker analysis of the phase 3 JAVELIN Bladder 100 trial. Nature Medicine 27:12, pages 2200-2211.
Crossref
Crossref
Elena Fountzilas, Razelle Kurzrock, Henry Hiep Vo & Apostolia-Maria Tsimberidou. (2021) Wedding of Molecular Alterations and Immune Checkpoint Blockade: Genomics as a Matchmaker. JNCI: Journal of the National Cancer Institute 113:12, pages 1634-1647.
Crossref
Crossref
Dapeng Hao, Siyuan He, Kazuto Harada, Melissa Pool Pizzi, Yang Lu, Pujun Guan, Lu Chen, Ruiping Wang, Shaojun Zhang, Matheus Sewastjanow-Silva, Ahmed Abdelhakeem, Namita Shanbhag, Manoop Bhutani, Guangchun Han, Jeffrey H Lee, Shuangtao Zhao, Brian Weston, Mariela Blum Murphy, Rebecca Waters, Jeannelyn Santiano Estrella, Sinchita Roy-Chowdhuri, Qiong Gan, Ju-Seog Lee, Guang Peng, Samir M Hanash, George Adrian Calin, Xingzhi Song, Jianhua Zhang, Shumei Song, Linghua Wang & Jaffer A Ajani. (2021) Integrated genomic profiling and modelling for risk stratification in patients with advanced oesophagogastric adenocarcinoma. Gut 70:11, pages 2055-2065.
Crossref
Crossref
Michael J Wagner, Megan Othus, Sandip P Patel, Chris Ryan, Ashish Sangal, Benjamin Powers, G Thomas Budd, Adrienne I Victor, Chung-Tsen Hsueh, Rashmi Chugh, Suresh Nair, Kirsten M Leu, Mark Agulnik, Elad Sharon, Edward Mayerson, Melissa Plets, Charles Blanke, Howard Streicher, Young Kwang Chae & Razelle Kurzrock. (2021) Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART). Journal for ImmunoTherapy of Cancer 9:8, pages e002990.
Crossref
Crossref
Richard S. P. Huang, James Haberberger, Karthikeyan Murugesan, Natalie Danziger, Matthew Hiemenz, Eric Severson, Daniel L. Duncan, Shakti H. Ramkissoon, Jeffrey S. Ross, Julia A. Elvin & Douglas I. Lin. (2021) Clinicopathologic and genomic characterization of PD-L1-positive uterine cervical carcinoma. Modern Pathology 34:7, pages 1425-1433.
Crossref
Crossref
Alfredo Addeo, Alex Friedlaender, Giuseppe L. Banna & Glen J. Weiss. (2021) TMB or not TMB as a biomarker: That is the question. Critical Reviews in Oncology/Hematology 163, pages 103374.
Crossref
Crossref
Shin Hye Yoo, Jihui Yun, Bhumsuk Keam, Seung-Pyo Hong, Chan-Young Ock, Jaemoon Koh, Sehui Kim, Yoon Kyung Jeon, Kyeong Cheon Jung, Miso Kim, Tae Min Kim, Dong-Wan Kim, Jong-Il Kim & Dae Seog Heo. (2021) Discovery of acquired molecular signature on immune checkpoint inhibitors in paired tumor tissues. Cancer Immunology, Immunotherapy 70:6, pages 1755-1769.
Crossref
Crossref
Ayal B Gussow, Eugene V Koonin & Noam Auslander. (2021) Identification of combinations of somatic mutations that predict cancer survival and immunotherapy benefit. NAR Cancer 3:2.
Crossref
Crossref
Zhu Zeng, Biao Yang & Zhengyin Liao. (2021) Biomarkers in Immunotherapy-Based Precision Treatments of Digestive System Tumors. Frontiers in Oncology 11.
Crossref
Crossref
Denis L. Jardim, Aaron Goodman, Debora de Melo Gagliato & Razelle Kurzrock. (2021) The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker. Cancer Cell 39:2, pages 154-173.
Crossref
Crossref
Amin Haghighat Jahromi, Donald A. Barkauskas, Matthew Zabel, Aaron M. Goodman, Garret Frampton, Mina Nikanjam, Carl K. Hoh & Razelle Kurzrock. (2020) Relationship between tumor mutational burden and maximum standardized uptake value in 2-[18F]FDG PET (positron emission tomography) scan in cancer patients. EJNMMI Research 10:1.
Crossref
Crossref
Rui Li, Dongsheng Han, Jiping Shi, YanXi Han, Ping Tan, Rui Zhang & Jinming Li. (2020) Choosing tumor mutational burden wisely for immunotherapy: A hard road to explore. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1874:2, pages 188420.
Crossref
Crossref
Z. A.-G. Radzhabova, M. Д. Kotov, A. S. Mitrofanov, Z. S. Bekyasheva & E. V. Levchenko. (2020) Immunotherapy for regional, recurrent and metastatic head and neck cancer: recent advances and future directions. Medical alphabet:20, pages 60-69.
Crossref
Crossref
Jacob J. Adashek, Pedro Nazareth Aguiar Junior, Natalie Galanina & Razelle Kurzrock. (2019) Remembering the forgotten child: the role of immune checkpoint inhibition in patients with human immunod eficiency virus and cancer. Journal for ImmunoTherapy of Cancer 7:1.
Crossref
Crossref
Zhishan Chen, Wanqing Wen, Jiandong Bao, Krystle L. Kuhs, Qiuyin Cai, Jirong Long, Xiao-ou Shu, Wei Zheng & Xingyi Guo. (2019) Integrative genomic analyses of APOBEC-mutational signature, expression and germline deletion of APOBEC3 genes, and immunogenicity in multiple cancer types. BMC Medical Genomics 12:1.
Crossref
Crossref
John D. Cramer, Barbara Burtness & Robert L. Ferris. (2019) Immunotherapy for head and neck cancer: Recent advances and future directions. Oral Oncology 99, pages 104460.
Crossref
Crossref
Yongfeng Wu, Jinming Xu, Chengli Du, Yihua Wu, Dajing Xia, Wang Lv & Jian Hu. (2019) The Predictive Value of Tumor Mutation Burden on Efficacy of Immune Checkpoint Inhibitors in Cancers: A Systematic Review and Meta-Analysis. Frontiers in Oncology 9.
Crossref
Crossref